Yu Qian, Ahmed Osman, Chen Jiaqi, Islam Yousuf, Funaki Brian, Patel Mikin
Department of Radiology, University of Chicago Medical Center, University of Chicago, Chicago, IL, 60637, USA.
Chicago Medical School, 3333 N Green Bay Rd, North Chicago, IL, 60064, USA.
CVIR Endovasc. 2024 Nov 6;7(1):78. doi: 10.1186/s42155-024-00492-0.
Obsidio conformable embolic (OCE, Boston Scientific, MA) is a novel, radiopaque and conformable embolic. The purpose of this report is to describe its use for treatment of acute intra-abdominal hemorrhages.
Three patients presented with acute hemorrhage and were treated with OCE, including post-paracentesis hemorrhage, penetrating trauma to the liver, and blunt trauma in the spleen. All cases were performed under moderate sedation, with hemostasis achieved by end of procedure using less than 1 vial of OCE (0.2-0.4 ml). No severe adverse events occurred. None required repeated treatment.
OCE is a safe and effective embolic agent for treatment of intra-abdominal or visceral hemorrhage. Future studies with larger sample sizes and longer follow-up are warranted.
Obsidio顺应性栓塞剂（OCE，波士顿科学公司，马萨诸塞州）是一种新型的、不透射线且顺应性良好的栓塞剂。本报告的目的是描述其用于治疗急性腹腔内出血的情况。
3例急性出血患者接受了OCE治疗，包括腹腔穿刺后出血、肝脏穿透伤和脾脏钝挫伤。所有病例均在中度镇静下进行，手术结束时使用少于1瓶OCE（0.2 - 0.4毫升）实现止血。未发生严重不良事件。无一例需要重复治疗。
OCE是治疗腹腔内或内脏出血的一种安全有效的栓塞剂。有必要进行更大样本量和更长随访时间的未来研究。
